McGill University Department of Ophthalmology

McGILL OPHTHALMOLOGY CLINICAL DAY 2016

Cataracts

Centre Mont-Royal 2200 Mansfield, International Room

Montreal, Quebec

Friday, June 3, 2016

Featuring: Warren Hill, MD, FACS Bonnie Henderson, MD

Kashif Baig, MD, CM, MBA Paul Harasymowycz, MD,MSC

Sébastien Gagné, MD and faculty of the McGill Department of Ophthalmology

ORGANIZED BY: Hady Saheb, MD, MPH, Chair, McGill Ophthalmology Day Planning Committee

Leonard A. Levin, MD, PhD, Chair, McGill Department of Ophthalmology Mahshad Darvish MDCM, MBA, Marino Discepola MD, John Galic MD

Agenda

7:00 – 8:00 a.m. Registration and Breakfast 8:00 – 8:05 a.m. Introduction by McGill University Department of Ophthalmology Chairman

Leonard A. Levin MD, PhD 8:05 – 8:10 a.m. Introduction by McGill Day 2016 Chair

Hady Saheb MD, MPH CATARACTS: BACK TO THE FUTURE

8:10 – 8:30 a.m. History of Cataract Surgery – From Cryo to Femto in 40 Years Susan Lindley, MD

8:30 – 8:35 a.m. Discussion (5 min)

Femtosecond Laser-Assisted Cataract Surgery (FLACS):

8:35 – 8:45 a.m. What is the Evidence?

Paul Harasymowycz MD, MSC

8:45 – 9:05 a.m. Panel on Surgical Pearls and Pitfalls Paul Harasymowycz MD, MSC Sébastien Gagné, MD Conrad Kavalec, MD

9:05 – 9:15 a.m. The Role of FLACS in the Public System Conrad Kavalec, MD

9:15 – 9:20 a.m. Discussion (5 min)

9:20 – 9:35 a.m. Splash: What’s New in Cataract Surgery?

Intraoperative Aberrometry Mikel Mikhail, MD iTrace Lauren French, MD Dropless Cataract Surgery: Intravitreal Injections Darren Albert, MD

9:35 – 9:40 a.m. Discussion

9:40 – 10:05 a.m. THE DARIO LORENZETTI LECTURE: IOL Power Calculation Based in Pattern Recognition, Independent of Vergence Formulas and the Effective Lens Position Warren E. Hill, MD, FACS

10:05 – 10:10 a.m. Discussion

10:10 – 10:20 a.m. Resident Involvement in Cataract Surgery Jean Deschênes, MD

10:20 – 10:30 a.m. Discussion 10:30 – 10:50 a.m. Break

ATIOLS

10:50 - 11:10 a.m. Presbyopic Correction Marino Discepola, MD

All about TORICS

11:10 – 11:15 a.m. Barrett + Olsen Susan Wakil, MD 11:15 – 11:30 a.m. Preoperative Measurements and Corneal Marking Techniques, and Do We Need Them

Anymore? Mahshad Darvish-Zargar, MD, MBA

11:30 – 11:45 a.m. Postop IOL Rotation: How to Prevent, Diagnose, and Treat Darren Albert, MD

11:45 – 12:05 p.m. Discussion 12:05 – 12:15 p.m. Practice Management: ATIOLs in the Public System

Marino Discepola, MD 12:15 – 12:25 p.m. Post-Refractive IOL Calculations

Johanna Choremis, MD

12:25 – 12:45 p.m. THE SEAN MURPHY LECTURE: Negative Dysphotopsias – the Unsolved Mystery Bonnie An Henderson, MD

12:45 – 1:00 p.m. Discussion

1:00 – 1:45 p.m. LUNCH

CATARACTS AND COMORBIDITIES

1:45 – 1:55 p.m. Top 5 Things to Know if Operating on a Retina Patient John Galic, MD

1:55 – 2:05 p.m. Top 5 Things to Know if Operating on a Glaucoma Patient Hady Saheb, MD, MPH

2:05 – 2:15 p.m. Top 5 Things to Know if Operating on a Cornea Patient

Devinder Cheema, MD

2:15 – 2:25 p.m. Top 5 Things to Know if Operating on a Uveitis Patient Karin Oliver, MD

2:25 – 2:35 p.m. Top 5 Things to Know if Operating on a Strabismus Patient

Michael Flanders, MD 2:35 – 2:45 p.m. Discussion 2:45 – 3:05 p.m. Understanding Corneal Aberrations

Warren E. Hill, MD, FACS

3:05 – 3:15 p.m. Discussion 3:15 – 3:35 p.m. Break

UH OH: KEEPING YOUR COOL IN DIFFICULT CASES

3:35 – 3:50 p.m. Houston, We Have a Problem: Management of Complicated Cases Bonnie An Henderson, MD

3:50 – 4:10 p.m. Discussion

4:10 – 4:20 p.m. Posterior Polar Cataracts Sébastien Gagné, MD

4:20 – 4:30 p.m. Vitrectomy for the Anterior Segment Surgeon Michael Kapusta, MD

4:30 – 4:50 p.m. When the Capsule is Gone: IOL Options and How to Choose Kashif Baig, MD, CM, MBA

4:50 – 5:05 p.m. Discussion 5:05 – 5:25 p.m. Resident Complication Panel: What Would You Do If You Were Supervising Surgeon

in This Case? Rayan Al-Shareef MD, Darren Albert MD, Hady Saheb MD MPH, Bonnie An Henderson MD, Kashif Baig, MD CM MBA

5:25 – 5:30 p.m. Closing Remarks Hady Saheb, MD, MPH

LEARNING OBJECTIVES FOR THE McGILL OPHTHALMOLOGY CLINICAL DAY

June 3, 2016 Centre Mont-Royal, Montréal, Québec

At the end of the program, participants will be able to: Compare different methods of preparing for the implementation of TORIC

lenses Assess possible reasons for an unhappy patient following cataract surgery Contrast intricacies of cataract surgery in patients with ocular

comorbidities Build on current approaches of managing intraoperative complications Discuss the impact these recent developments could have on their

practice.

How did we do?

Please evaluate your experience at today’s McGill Ophthalmology Clinical Day by completing the survey at https://www.surveymonkey.com/r/GCHTYV7

Your responses will help us plan for next year.

Applying for CME Credit? This meeting is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada. This meeting was approved by the Canadian Ophthalmological Society. Physicians may claim a maximum of 8 hours.

Physicians should only claim credit commensurate with the extent of their participation in the learning activity.

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.”

To receive a certificate of attendance in order to claim credits, please complete the survey at https://www.surveymonkey.com/r/GCHTYV7 We will be pleased to send you a certificate by email upon completion of the survey.

Bonnie An Henderson is an internationally-recognized expert in cataract and refractive surgery, specializing in complicated anterior segment surgery. She is currently a partner at Ophthalmic Consultants of Boston and a Clinical Professor at Tufts University School of Medicine. Dr. Henderson is the Associate Editor for the Journal of Refractive Surgery and Associate Editor for Eyeworld for the American Society of Cataract and Refractive Surgery. She serves on the editorial advisory board of Eyenet Magazine of the American Academy of Ophthalmology, and serves on the editorial boards of Ocular Surgery News, Cataract and Refractive Surgery Today, and Advanced Ocular Care. She serves on a number of committees for the

American Academy of Ophthalmology and the American Society of Cataract and Refractive Society. She will serve as the President of American Society of Cataract and Refractive Surgery in 2017.

Dr. Henderson has authored over 125 articles, papers, book chapters, and abstracts and has delivered over 275 invited lectures worldwide. She has published 4 textbooks in cataract and refractive surgery with her 5th book due out in 2015. Her textbook, Essentials of Cataract Surgery, is one of the most commonly used textbooks to teach cataract surgery in the United States. Dr. Henderson’s principal research involves cataract surgery outcomes and innovative methods of teaching, including the development of a digital-based method for teaching cataract surgery, supported by a Department of Defense TATRIC grant. She has invented and commercialized a number of medical instruments including the modified capsule tension ring, astigmatism correcting markers, and a capsule polisher, for which she donates her interests to charity.

Dr. Henderson has been awarded an Achievement Award, the Secretariat Award, and the Senior Achievement Award by the American Academy of Ophthalmology, “Best of” awards from the American Society of Cataract and Refractive Surgery for her research and films, and the “Teacher of the Year” award from Harvard Medical School. She has been awarded the Visionary Award by the American- European Congress of Ophthalmic Surgery and received the Suzanne Veronneau-Troutman Award from Women in Ophthalmology. She has been chosen by her peers nearly every year for the past consecutive 12 years as “Top Doctor” by Boston Magazine, as “Top 100 Doctors in the United States” by the US New Report, “Top Doctor” by Castle Connolly, and a “Top Surgeon” by Becker’s ASC Report.

Dr. Henderson completed her ophthalmology residency at Harvard Medical School, Massachusetts Eye and Ear Infirmary. She graduated from Dartmouth College and from Dartmouth Medical School with high honors. She serves on the Board of Overseers at the Geisel School of Medicine at Dartmouth, the Executive Committee of American Society of Cataract and Refractive Surgery, the Executive Board of the Massachusetts Society of Eye Physicians and Surgeons, and has served on the Physician Board of Directors at the Massachusetts Eye and Ear Infirmary. Married with three children, her interests include culinary arts and competing in triathlons.

Dr. Warren Hill has been in private practice in Mesa, Arizona for the past 30 years. He completed his ophthalmology training at the University of Rochester in New York and has since devoted his career to challenging anterior segment surgery and the mathematics of intraocular lens power calculations. He is best known for his work helping physicians to obtain accurate IOL power calculations. His web site doctor-hill.com and the ASCRS post-refractive calculator, developed with Doug Koch and Li Wang, are two of the most popular IOL power calculation resources in ophthalmology, with a combined

total of over 200,000 visits per year. Dr. Hill has published extensively, served as visiting professor for grand rounds at many institutions, has delivered 18 named lectureships and has made 650 presentations at both national and international meetings in 36 countries. In 2007 Dr. Hill was appointed the Cataract and Anterior Segment Subspecialty Editor for the American Academy of Ophthalmology's Ophthalmic News and Education (O.N.E.) Network, a position he held until 2010. He has performed live surgery at ophthalmology meetings in North America, South America and Europe and is a member of the prestigious International Intraocular Implant Club. In 2014, Dr. Hill gave the American Society of Cataract and Refractive Surgery Innovator's Lecture and in 2015 he gave the American Academy of Ophthalmology’s Charles Kelman Lecture. Aside from the practice of ophthalmology, Dr. Hill’s other passion is flying military airplanes in air shows as a member of a close formation demonstration team for which is licensed as a multi-engine commercial pilot. Each year, his team regularly performs at a wide variety air shows, including the EAA (Oshkosh) AirVenture, the largest air show in North America.

Kashif Baig

Dr. Baig is a Cornea, Anterior Segment, and Refractive Surgeon providing tertiary and quaternary level care at the University of Ottawa Eye Institute. He is the President of the Canadian Cornea, External Disease, and Refractive Surgery Society. He is also an Assistant Professor at the University of Ottawa, Cornea Consultant at the Children's Hospital of Eastern Ontario, Clinical Investigator in Regenerative Medicine at the Ottawa Hospital Research Institute, and Director of Clinical and Research Fellowships in Cornea, Anterior Segment, and Refractive Surgery.

He has delivered over 100 lectures; has done over 120 research paper and poster presentations; has instructed courses at ESCRS, ASCRS, and COS; and has trained 12 clinical and research fellows in the last 7 years. He completed his medical and residency training at McGill University, Master of Business Administration Degree (specializing in Health Services Management) at McMaster University, and Fellowship training in the United States. He has a strong interest in the development and implementation of surgical innovations in corneal and anterior segment surgery.

Sébastien Gagné

Dr. Gagné’s primary interests are in surgical glaucoma, phacorefractive surgery and clinical research. He studied medicine at the Université de Sherbrooke from 1997 to 2001 and completed his specialty training in ophthalmology there in 2006. In 2007, in the aim of furthering his knowledge and learning new surgical techniques, he completed a one-year subspecialty training program at the University of Toronto under the supervision of Drs. Ike K. Ahmed and Thomas B. Klein. A glaucoma expert, he has developed expertise in the treatment of complicated cataract cases and in the reconstruction of the anterior segment.

A member of the Royal College of Physicians and Surgeons of Canada and a research clinician, Dr. Gagné is also professor of clinical teaching at the Faculty of Medicine of the Université de Montréal and participates in the training of future ophthalmologists at the Centre hospitalier de l’Université de Montréal (CHUM), Hôpital Notre-Dame since 2007. Dr. Gagné is a founding member and medical director of the Institut de l’oeil des Laurentides. He is a fan of hockey and Star Wars, and is the proud father of two sons and a daughter.

Paul Harasymowycz

Throughout his career, Dr Harasymowycz has devoted himself to teaching, researching and medical entrepreneurship. After finishing his studies in medicine, he pursued a residency at the Université de Montréal as chief resident. After completing his fellowship at the Will’s Eye Hospital in Philadelphia in 2001, he started working as a clinician, surgeon and researcher at Maisonneuve-Rosemont Hospital and at the Centre de recherche Guy-Bernier. In parallel, he has also been teaching at the ophthalmology department of the Université de Montréal where today he is chief of glaucoma. His interest in and devotion to the treatment of glaucoma led him to found the Bellevue Ophthalmology Clinics, the Montreal Glaucoma Institute and the Quebec Glaucoma Foundation.

Dr Harasymowycz has received many research grants and his research focuses primarily on the detection of glaucoma and new surgical treatment options and techniques for glaucoma surgery and cataract surgery. He has a passion for teaching medical students, residents and fellows in glaucoma. He is solicited nationally and internationally to present and teach surgical techniques at professional congresses, specialist meetings and universities. He is a member of the glaucoma committee of the American Society of Cataract and Refractive Surgery (ASCRS) and the Board of the Association des Médecins Ophtalmologistes du Québec (AMOQ). He has published over fifty articles in scientific peer-reviewed journals and has authored chapters on glaucoma in several published books.

Biography of Dr. Sean Murphy

(1924 - )

A 1943 graduate of Harvard, Dr. Murphy received his medical degree from McGill in 1947. From 1952 to 1955 he served in the Royal Canadian Air Force, where he was in charge of ophthalmological services. Then in 1955 he joined the McGill Department of Ophthalmology and the staff of the RVH. For eighteen years thereafter he saw consultations from the MNI and taught neuro-ophthalmology, at the same time gradually furthering his practice of retinal surgery.

In 1970 Dr. Murphy was appointed Ophthalmologist-in-Chief at the RVH, and Professor and Chairman of the McGill Department of Ophthalmology in 1975. The Dean, Dr. Samuel O. Friedman, gave him a mandate to unify the department and create a harmonious relationship between the four hospital departments. This was no easy matter as the Chairman had virtually no authority over the hospital departments.

His first initiative was to form a McGill departmental Executive Committee. The four hospital chiefs were invited to be members. They were Dr. Dario Lorenzetti (MGH), Dr. John Little (MCH), Dr. Joel Rosen (JGH), and Dr. Murphy (RVH). The Executive Committee met regularly, once a month, and among the many subjects discussed were: residents, medical students, teaching, staff GFTs, recruitment, subspecialization, research, fund raising, space, amalgamation, and the development of centers of excellence.

The Executive Committee proved to be successful in cementing better interhospital relations. Its creation was an important step in assuring the future development of the department. Dr. Murphy promoted the training and recruitment of subspecialists and geographic full-time staff. He felt it was a priority to send graduating residents away for further specialized training and, wherever possible, to offer them GFT positions on their return. Supporting departmental research, he emphasized the importance of having basic scientists in the

department. He also helped develop a strong McGill Ocular Pathology unit with Drs. Mourad Khalil, Esmond Gordon and Seymour Brownstein, and encouraged the development of the Low Vision Clinic. He participated in the meetings of the Cogan Ophthalmic History Society and the American Osler Society.

Realizing that ophthalmology was under-valued in hospitals and universities across Canada, Dr. Murphy accepted several administrative positions outside of McGill and its teaching hospitals. He became President of the Canadian Ophthalmological Society, President of the Association des médecins ophtalmologistes du Québec, and for two years was Chief Examiner of the Royal College. He was awarded the Order of Canada in 1976, the medal of the Canadian Ophthalmological Society in 1987, and in 2007 received the society’s Lifetime Achievement Award. In 1989 the Department of Ophthalmology established an annual lecture in his honour.

He established the annual Clinical and Scientific Day in 1978 with the help of Dr. Bruce Jackson. It continues to the present day, and provides a forum for the residents to present the results of their research – the research being done with supervision of a member of the staff. Dr. Murphy believed strongly in community activities and for ten years was President of the Montreal Museum of Fine Arts, which involved being an active fundraiser for the museum, a position which frequently helped in the search for funds for academic ophthalmology. McGill and the hospitals did not provide sufficient funds for research as well as the resident program with the result that funding became a priority. Dr. Murphy retired as Ophthalmologist-in-Chief at the RVH and Chairman of the McGill Department of Ophthalmology in 1986.

In 1991 Dr. Murphy was appointed Interim Chairman of the McGill Department until 1993. He is now a retired member of the Department of Ophthalmology and resides in Montreal, Quebec.

Excerpt from History of McGill Department of Ophthalmology’, Sean B. Murphy, 1990.

Biography of Dr. Dario Lorenzetti (1936 - 1994)

Dr. Lorenzetti graduated in medicine from McGill in 1960. He then completed the Ophthalmology residency program at the MGH, followed by a fellowship in external disease with Dr. Herbert Kaufman at the University of Florida, Gainsville. In 1967, Dr. Lorenzetti returned to the MGH, and was appointed a GFT ophthalmologist. As a researcher, teacher, and physician, Dr. Lorenzetti’s contributions to the MGH and McGill Ophthalmology were important. For example, in the 1960s little ophthalmological research was being conducted, either at McGill or at its teaching hospitals. However, one exception to this situation was the work being pursued by Dr. Lorenzetti. After arriving at the MGH, he continued his studies in external disease, worked with several Fellows, and supervised corneal research. His research work, supported by grants, was important, as it signaled the later advent of clinical scientists and furthered the research projects and initiatives previously begun by Dr. Peter Davis at the RVH. He was a valued member of the departmental executive committee, and could be counted on to come up with better ways of doing things. In his administrative functions, Dr. Lorenzetti was an excellent and reliable administrator; one could always count on him. If he said he would do it, it was done. Indeed his administrative and organizing skills were reflected in his heavy involvement with the MGH project to secure new facilities for the hospital’s ophthalmology department and clinic on the 6th floor of Livingston Hall. Beyond his research and teaching duties, as well as his official administrative functions, Dr. Lorenzetti held a number of additional university and non-university positions. In 1980 he was appointed Chief Examiner for the Royal College of Physicians and Surgeons. In addition, an interest in medical education led to his chairing the Canadian Ophthalmological Society’s Continuing Medical Education Committee for several years. Also in the late 1980s, Dr. Lorenzetti was a member of the external disease group, composed of himself and

Drs. Bruce Jackson and Joel Rosen. The group was trying to obtain greater subspecialty amalgamation between the hospitals, and met for external disease clinics regularly in the different hospitals, where patients were examined and discussed. As Chairman of the Postgraduate Committee, he organizing the residents’ rotations and their Thursday morning lectures. The teaching offered in the lectures was of high quality and given roughly in parallel with the American Academy of Ophthalmology schedule of subjects. These sessions were instituted in the early 1970s and attended by all the residents. Their attendance was mandatory and they were excused from all other duties to attend. At the conclusion of a series of lectures on a given subject area, and after discussion with the teachers involved, a distinguished visiting professor in that field was invited to spend time with the residents and give a lecture to the whole department. Most frequently these speakers came from the United States, Canada, and occasionally other countries. Organizing this far-flung training program in four hospitals was complex. However, Dr. Lorenzetti always had everything in good order and submitted on time. Besides being a good organizer and administrator of medical matters, Dr. Lorenzetti was also renowned for organizing and participating in festive occasions - especially senior resident dinners and more informal events. Dr. Lorenzetti was friendly, well liked and his warm hearted support of residents and staff was noticed and appreciated by all. He looked after his staff’s interests admirably, often seeking improved funding and always supporting them. He presented his points of view to others with clarity and conviction. Always logical, and a skilled debater, he fought hard for what he believed. Understandably, both the hospital and university community were greatly saddened by his premature death in 1994 as were his friends and numerous patients. In his honour, the Canadian Ophthalmological Society launched the annual Dario Lorenzetti Lecture. Similarly, the McGill Department of Ophthalmology also established an annual lecture in memory of Dr. Lorenzetti.

Excerpt from History of McGill Department of Ophthalmology’, Sean B. Murphy, 1990.

DARIO W.C. LORENZETTI LECTURES 1996 –

2016 Warren Hill, M.D., F.A.C.S. East Valley Ophthalmology, Mesa, AZ 2015 Christopher J. Rapuano. M.D. Wills Eye Institute, Philadelphia, PA 2013 John G. Flanagan, Ph.D. Vision Science, University of California, Berkeley, CA 2012 Rando Allikmets, Ph.D. Columbia University, New York, NY 2011 Austin Roorda, M.D. University of California, Berkeley, CA 2009 Debra A. Goldstein, M.D. McGill University 2008 Miguel N. Burnier Jr., M.D., Ph.D. McGill University 2007 Peter J. Savino, M.D. Wills Eye Hospital, Philadelphia, PA 2006 James J. Augsburger, M.D. University of Cincinnati College of Medicine, Cincinnati, OH 2005 J. William Harbour, M.D. Bascom Palmer Eye Institute, University of Miami Health System, Miami, FL 2004 Arthur B. Leith, M.D. McGill University 2003 Stephen M. Drance, M.D. University of British Columbia, Vancouver, BC 2002 Alan F. Cruess, M.D. Dalhousie University, Halifax, NS 2001 Donald S. Minckler, M.D. University of California, Irvine, CA 2000 Richard K. Parrish, M.D. Bascom Palmer Eye Institute, University of Miami Health System, Miami, FL 1999 Kenneth R. Kenyon, M.D. New England Eye Centre, Boston, MA 1998 Nabil E. Saheb, M.D. McGill University 1997 Ramon L. Font, M.D. Baylor College of Medicine, Houston, TX 1996 David J. Apple, M.D Medical University of South Carolina, Charleston, SC

SEAN B. MURPHY LECTURES 1989 -

2016 Bonnie Henderson, MD, Cornea Tufts University School of Medicine 2015 Todd Margolis, MD, PhD, Uveitis Washington University School of Medicine, USA 2014 Richard K. Parrish II, MD, Glaucoma

Bascom Palmer Eye Institute, Miami, Florida, USA

2013 Emily Chew, MD, Retina

National Institutes of Health (NIH), Bethesda, Maryland, USA

2012 George B. Bartley, MD, Oculoplastics

Mayo Clinic in Florida, Rochester, Minnesota, USA

2011 Harry A. Quigley, MD, Glaucoma

Wilmer Ophthalmological Institute, John Hopkins University School of Medicine, Baltimore, MD

2010 Sohan Hayreh, MD, Neuro-Ophthalmology University of Iowa, USA 2009 Warren Hill, MD, Cataracts East Valley Ophthalmology, Mesa, Arizona 2008 Dr. Nabil Saheb, Glaucoma

Department of Ophthalmology, McGill University

2007 Neil Miller, MD, Neuro-Ophthalmology Johns Hopkins Hospital, Baltimore, Maryland 2006 Bryan Arthurs, MD, Oculoplastics

Department of Ophthalmology, McGill University

2005 Stanley Chang, MD, Retina Columbia University, New York, N.Y. 2004 John T. Flynn, MD, Pediatric

Ophthalmology/Strabismus Harkness Eye Institute, New York, N.Y.

2003 Alain Rousseau, MD, Retina/Ocular Pathology Laval University, Quebec City 2002 Jerry Shields, MD, Ophthalmic Oncology/Retina

Vitreous Will’s Eye Institute, Philadelphia, Pennsylvania 2001 Bruce Jackson, MD, Cornea/External Disease University of Ottawa Eye Institute, Ottawa

2000 Jean Deschênes, MD, Uveitis, Cornea/External Disease Department of Ophthalmology, McGill University

1999 Lanning Kline, MD, Neuro-Ophthalmology Birmingham, Alabama 1998 Rubens Belfort, MD, Cornea/External Disease Sao Paulo, Brazil 1997 Raymond Leblanc, MD, Glaucoma Halifax, Nova Scotia 1996 Frederick Jakobiec, MD, Ophthalmic

Oncology/Ophthalmic Pathology Massachusetts Eye and Ear Infirmary, Boston, Massachusetts

1995 Duncan Anderson, MD, Neuro-Ophthalmology Vancouver, British Columbia 1994 Lorenz E. Zimmerman, MD, Ophthalmic

Pathology Armed Forces Institute of Pathology, Washington, D.C.

1993 Howard Tanenbaum, MD, Vitreoretinal Albany, New York 1992 Mark Abelson, MD, Cornea/External

Disease/Optics/Refraction Boston, Massachusetts 1991 Elliott B. Werner, MD, Glaucoma Philadelphia, Pennsylvania 1990 E.R. Simpson, MD, Ocular Oncology Toronto, Ontario 1989 Brian Yonge, MD Mayo Clinic, Rochester, Minnesota

The Department of Ophthalmology, McGill University wishes to thank the following

companies for their support of the Department, for the 39th Annual McGill Ophthalmology Research Day 2016

and throughout the years.

Gold sponsor:

Silver sponsor:

Bronze sponsor:

ALL17698_01_Retina Society Conference Program Ad EN17698_01

Notepad

Allergan

Lora

DrH, CC

Kendra

4/0 – cmyk

7.5"x9.5"

.125" within

N/A

100%

3 5100%

PMS

01/28/16

PMS PMS PMS PMS FOIL

see whatwe see

Allergan markets a portfolio of best-in-class products that provide valuable treatments

for the eye care, central nervous system, medical aesthetics, gastroenterology, women’s health,

urology, cardiovascular and anti-infective therapeutic categories, providing patients around

the globe with increased access to affordable, high-quality medicines.

Allergan is an industry leader in research and development, with one of the broadest

development pipelines in the pharmaceutical industry.

F O R M O R E I N F O R M A T I O N , V I S I T T H E A L L E R G A N B O O T H

A N D T A L K T O A R E P R E S E N T A T I V E .

T M / ® M A R K S A R E O W N E D B Y A L L E R G A N I N C . X E N ® I S A R E G I S T E R E D T R A D E M A R K O F A Q U E S Y S , I N C . , A N A L L E R G A N A F F I L I A T E ,

U S E D U N D E R L I C E N S E B Y A C T A V I S S P E C I A L T Y P H A R M A C E U T I C A L S C O . © 2 0 1 6 A L L E R G A N . A L L R I G H T S R E S E R V E D .

A P C 0 8 J S 1 6

ALL17698_01_RetinaSocietyConf_ProgramAd_EN.indd 1 2016-01-29 9:41 AM

By 2050 the world’s population over 60 will have doubled to two billion, making age-related illness an even greater challenge for society.That’s why we’re seeking to help people stay healthier and more active in later life, be it through more targeted treatments for cancer

and cardiovascular conditions, solutions for eye diseases, or ways to keep those with arthritis moving. Because life shouldn’t stop at 60 – not by any means.To find out how our innovations are helping to change lives for the better, visit www.bayer.ca

© 2016 Bausch & Lomb Incorporated. BLS05655 TP12894

Each day, we have 14 billion little reminders to continue

advancing eye health.

From the moment we open our eyes and start to viewthe possibilities of each new day, we look at how we can improve the well-being of the world’s 14 billion eyes. Will this be the day when one of us unlocks a way to eliminate visual impairment in newborns? Or strikes upon a treatment that actually helps the eye heal itself? To us, these are not some distant hopes. They are the daily questions that add new urgency to all we do and everything we see for the future. We’re Bausch + Lomb, a company solely focused on advancing the vision and care of the world’s eyes.

www.novartis.ca

Novartis Pharmaceuticals Canada Inc. is one of the country’s leading

healthcare companies committed to improving the health of Canadians.

We strive to discover and develop medicines that make a real difference.

There can be no delay.

Patients are waiting.

Novartis Pharma Canada inc. est un chef de file national dans le domaine

de la santé qui s’engage à améliorer la santé des patients.

Nous aspirons à découvrir et à mettre au point des médicaments qui font

une véritable différence.

Il faut accélérer le pas.

Les patients attendent.

16-0238-Novartis-FP-EN-CMYK-ClinicalDay-v2.indd 1 2016-05-13 4:12 PM